Subtherapeutic dose lithium treatment induces behavioral and neuropathological changes in 3xTg‐AD Alzheimer's mice
The chronic lithium treatment significantly attenuates the pathological progression of AD, suggesting it as a potential therapeutic drug target for modifying AD. The study was funding by: São Paulo Research Foundation (FAPESP; 2021/06378-1).
Authors
- Monique Patrício Singulani (ORCID: https://orcid.org/0000-0001-7019-0485)
- Orestes Vicente Forlenza (ORCID: https://orcid.org/0000-0002-6962-5899)
- R. Camarini
- L. R. Giorgetti Britto
- Leda Leme Talib
Institutions
- Universidade de São Paulo (BR)
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70855_107377
- Primary Topic
- Bipolar Disorder and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00